Arid
DOI10.3389/fcell.2021.691161
Identification of Novel Metabolism-Associated Subtypes for Pancreatic Cancer to Establish an Eighteen-Gene Risk Prediction
Gao, Yang; Zhang, Enchong; Fei, Xiang; Kong, Lingming; Liu, Peng; Tan, Xiaodong
通讯作者Tan, XD (corresponding author), China Med Univ, Shengjing Hosp, Dept Gen Surg, Shenyang, Peoples R China.
来源期刊FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
ISSN2296-634X
出版年2021
卷号9
英文摘要Pancreatic cancer (PanC) is an intractable malignancy with a high mortality. Metabolic processes contribute to cancer progression and therapeutic responses, and histopathological subtypes are insufficient for determining prognosis and treatment strategies. In this study, PanC subtypes based on metabolism-related genes were identified and further utilized to construct a prognostic model. Using a cohort of 171 patients from The Cancer Genome Atlas (TCGA) database, transcriptome data, simple nucleotide variants (SNV), and clinical information were analyzed. We divided patients with PanC into metabolic gene-enriched and metabolic gene-desert subtypes. The metabolic gene-enriched subgroup is a high-risk subtype with worse outcomes and a higher frequency of SNVs, especially in KRAS. After further characterizing the subtypes, we constructed a risk score algorithm involving multiple genes (i.e., NEU2, GMPS, PRIM2, PNPT1, LDHA, INPP4B, DPYD, PYGL, CA12, DHRS9, SULT1E1, ENPP2, PDE1C, TPH1, CHST12, POLR3GL, DNMT3A, and PGS1). We verified the reproducibility and reliability of the risk score using three validation cohorts (i.e., independent datasets from TCGA, Gene Expression Omnibus, and Ensemble databases). Finally, drug prediction was completed using a ridge regression model, yielding nine candidate drugs for high-risk patients. These findings support the classification of PanC into two metabolic subtypes and further suggest that the metabolic gene-enriched subgroup is associated with worse outcomes. The newly established risk model for prognosis and therapeutic responses may improve outcomes in patients with PanC.
英文关键词pancreatic cancer transcriptome metabolic genes subtype risk model
类型Article
语种英语
开放获取类型Green Published, gold
收录类别SCI-E
WOS记录号WOS:000684954500009
WOS关键词MOLECULAR SUBTYPES ; PRECISION MEDICINE ; GENE ; TUMOR ; METHYLATION ; BALANCE
WOS类目Cell Biology ; Developmental Biology
WOS研究方向Cell Biology ; Developmental Biology
资源类型期刊论文
条目标识符http://119.78.100.177/qdio/handle/2XILL650/363277
作者单位[Gao, Yang; Fei, Xiang; Kong, Lingming; Liu, Peng; Tan, Xiaodong] China Med Univ, Shengjing Hosp, Dept Gen Surg, Shenyang, Peoples R China; [Zhang, Enchong] China Med Univ, Shengjing Hosp, Dept Urol, Shenyang, Peoples R China
推荐引用方式
GB/T 7714
Gao, Yang,Zhang, Enchong,Fei, Xiang,et al. Identification of Novel Metabolism-Associated Subtypes for Pancreatic Cancer to Establish an Eighteen-Gene Risk Prediction[J],2021,9.
APA Gao, Yang,Zhang, Enchong,Fei, Xiang,Kong, Lingming,Liu, Peng,&Tan, Xiaodong.(2021).Identification of Novel Metabolism-Associated Subtypes for Pancreatic Cancer to Establish an Eighteen-Gene Risk Prediction.FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY,9.
MLA Gao, Yang,et al."Identification of Novel Metabolism-Associated Subtypes for Pancreatic Cancer to Establish an Eighteen-Gene Risk Prediction".FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY 9(2021).
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Gao, Yang]的文章
[Zhang, Enchong]的文章
[Fei, Xiang]的文章
百度学术
百度学术中相似的文章
[Gao, Yang]的文章
[Zhang, Enchong]的文章
[Fei, Xiang]的文章
必应学术
必应学术中相似的文章
[Gao, Yang]的文章
[Zhang, Enchong]的文章
[Fei, Xiang]的文章
相关权益政策
暂无数据
收藏/分享

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。